FDA Approved: OXALIPLATIN — Supplemental Application (Winthrop U.S, a business of sanofi-aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for Oxaliplatin, a drug developed by Winthrop U.S, a business of sanofi-aventis U.S. LLC, indicating an update or additi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

SUPPL AP for OXALIPLATIN (OXALIPLATIN)